Drug Development Insights: What New Industry Data Reveals for 2026, Upcoming Webinar Hosted by Xtalks

Drug Development Insights: What New Industry Data Reveals for 2026, Upcoming Webinar Hosted by Xtalks In this free webinar, learn how today's industry trends and challenges are shaping drug ...
Business Insider

Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update

Interim analysis of Phase 1b clinical study of GT-02287, including biomarker and clinical endpoints, will be presented in oral symposium Company remains on track to initiate Phase 2 clinical trial of ...

Jeskell Systems Announces Immediate Availability of Supermicro AI Inference Server Amid Industry Hardware Shortages

Jeskell Systems announces immediate availability of Supermicro AI inference servers while industry supply shortages push typical deployments out 3–6 months. This Supermicro platform represents a rare ...
Quality Assurance & Food Safety

FDA to Hold Public Meeting on Dietary Supplements

Exploring the Scope of Dietary Supplement Ingredients” is scheduled for March 27, from 9 a.m.-3 p.m. EST, with in-person and virtual attendance options.

Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company’s AI-enabled Drug Development Strategy PHILADELPHIA, PA / ACCESS Newswire / March 10, 2026 / ...

Trump’s divisive FDA vaccine regulator self-destructs, will exit agency (again)

This will be Prasad’s second exit from the FDA during the current Trump administration. In July, he resigned amid his controversial handling of a gene therapy treatment for Duchenne muscular dystrophy ...

Stellarix Webinar Examines Strategic Pathways for F&B Industry to Navigate the GLP-1 Disruption

As GLP-1 adoption goes up, food companies must move beyond category trends. The next 12-18 months will be critical to ...

QSIT Is Ending: How to Achieve Audit Readiness for Medical Devices Under FDA QMSR, Upcoming Webinar Hosted by Xtalks

In this free webinar, see how audit readiness can be strengthened as the FDA transitions from QSIT to QMSR. Attendees will learn about the implications of the shift from inspection-based QSIT to a ...
TMCnet

A Modern Approach to Multiple Sclerosis Trials Applying Innovative Digital Endpoint Solutions, Upcoming Webinar Hosted by Xtalks

In this free webinar, see how a digital endpoint strategy can improve endpoint sensitivity and data quality in multiple sclerosis (MS) trials. Attendees will recognize how traditional MS endpoints can ...
Joplin Globe

Pentixapharm Receives FDA "Study May Proceed" Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program

U.S. Investigational New Drug (IND) applications for radiotheranostic pair PentixaFor and PentixaTher became active following completion of the FDA 30-day review period. Proposed phase I/II trial ...
Cure Today

FDA Clears Trial Application for FG001 in Brain Cancer

FDA IND clearance permits a U.S. phase 2 registration-oriented trial of FG001 in high-grade glioma, with first-patient-in expected during Q2 2026. Fluorescence-guided surgery with FG001 aims to ...